Atlas Trials

A Clinical Study With Tremelimumab as Monotherapy in Malignant Mesothelioma

Clinical trial NCT01649024 · UNKNOWN

Trial details

NCT number
NCT01649024
Sponsor
Azienda Ospedaliera Universitaria Senese
Status
UNKNOWN
Phase
Phase 2
Study type
INTERVENTIONAL
Malignant Mesothelioma
Start date
2009-05-01
Primary completion
2012-06-01
Enrollment
29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.